404 related articles for article (PubMed ID: 11423990)
1. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
2. Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding.
Päll T; Gad A; Kasak L; Drews M; Strömblad S; Kogerman P
Oncogene; 2004 Oct; 23(47):7874-81. PubMed ID: 15361838
[TBL] [Abstract][Full Text] [Related]
3. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation.
Zhu D; Bourguignon LY
Cell Motil Cytoskeleton; 1998; 39(3):209-22. PubMed ID: 9519902
[TBL] [Abstract][Full Text] [Related]
4. A peptide with three hyaluronan binding motifs inhibits tumor growth and induces apoptosis.
Xu XM; Chen Y; Chen J; Yang S; Gao F; Underhill CB; Creswell K; Zhang L
Cancer Res; 2003 Sep; 63(18):5685-90. PubMed ID: 14522884
[TBL] [Abstract][Full Text] [Related]
5. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.
Liao HX; Lee DM; Levesque MC; Haynes BF
J Immunol; 1995 Oct; 155(8):3938-45. PubMed ID: 7561101
[TBL] [Abstract][Full Text] [Related]
6. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
English NM; Lesley JF; Hyman R
Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
[TBL] [Abstract][Full Text] [Related]
7. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CD44 in pl85(neu)-transfected NIH3T3 cells promotes an up-regulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion.
Zhu D; Bourguignon L
Oncogene; 1996 Jun; 12(11):2309-14. PubMed ID: 8649770
[TBL] [Abstract][Full Text] [Related]
9. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells.
Subramaniam V; Gardner H; Jothy S
Exp Mol Pathol; 2007 Dec; 83(3):341-6. PubMed ID: 17945213
[TBL] [Abstract][Full Text] [Related]
11. Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
Gross N; Balmas K; Brognara CB
Cancer Res; 1997 Apr; 57(7):1387-93. PubMed ID: 9102228
[TBL] [Abstract][Full Text] [Related]
12. Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration.
Zhu D; Bourguignon LY
J Cell Physiol; 2000 May; 183(2):182-95. PubMed ID: 10737894
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
Guo Y; Ma J; Wang J; Che X; Narula J; Bigby M; Wu M; Sy MS
Cancer Res; 1994 Mar; 54(6):1561-5. PubMed ID: 7511044
[TBL] [Abstract][Full Text] [Related]
14. Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain.
Liu D; Zhang D; Mori H; Sy MS
Cell Immunol; 1996 Nov; 174(1):73-83. PubMed ID: 8929456
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
Sleeman JP; Arming S; Moll JF; Hekele A; Rudy W; Sherman LS; Kreil G; Ponta H; Herrlich P
Cancer Res; 1996 Jul; 56(13):3134-41. PubMed ID: 8674073
[TBL] [Abstract][Full Text] [Related]
16. MYCN-related suppression of functional CD44 expression enhances tumorigenic properties of human neuroblastoma cells.
Gross N; Balmas Bourloud K; Brognara CB
Exp Cell Res; 2000 Nov; 260(2):396-403. PubMed ID: 11035936
[TBL] [Abstract][Full Text] [Related]
17. Identification of two regions in the cytoplasmic domain of CD44 through which PMA, calcium, and foskolin differentially regulate the binding of CD44 to hyaluronic acid.
Liu D; Liu T; Sy MS
Cell Immunol; 1998 Dec; 190(2):132-40. PubMed ID: 9878114
[TBL] [Abstract][Full Text] [Related]
18. Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy.
Hibino S; Shibuya M; Engbring JA; Mochizuki M; Nomizu M; Kleinman HK
Cancer Res; 2004 Jul; 64(14):4810-6. PubMed ID: 15256450
[TBL] [Abstract][Full Text] [Related]
19. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg.
Annabi B; Bouzeghrane M; Moumdjian R; Moghrabi A; Béliveau R
J Neurochem; 2005 Aug; 94(4):906-16. PubMed ID: 15992376
[TBL] [Abstract][Full Text] [Related]
20. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration.
Okamoto I; Kawano Y; Tsuiki H; Sasaki J; Nakao M; Matsumoto M; Suga M; Ando M; Nakajima M; Saya H
Oncogene; 1999 Feb; 18(7):1435-46. PubMed ID: 10050880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
